The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease
dc.authorid | tatar, erhan/0000-0002-5068-4231 | |
dc.contributor.author | Tatar, Erhan | |
dc.contributor.author | Mirili, Cem | |
dc.contributor.author | Isikyakar, Tolgay | |
dc.contributor.author | Yaprak, Mustafa | |
dc.contributor.author | Guvercin, Guray | |
dc.contributor.author | Ozay, Emine | |
dc.contributor.author | Asci, Gulay | |
dc.date.accessioned | 2024-09-18T20:08:26Z | |
dc.date.available | 2024-09-18T20:08:26Z | |
dc.date.issued | 2016 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Objective: The purpose of this study was to investigate the association of the neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with the clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease (CKD).Material and Methods: A total of 165 patients over the age of 65, with stage 3-5 CKD, were enrolled in the study. The primary endpoints were all-cause of deaths and requirement of renal replacement therapy. The patients were divided into two groups according to delta neutrophil/lymphocyte ratio such as increased (group 1) and decreased or stable (group 2) groups.Results: The mean age was 73.86.1years and the mean follow-up was 30 +/- 13months. Thirty-one (18.7%) patients died during the follow-up period and 21 (13.4%) patients required renal replacement therapy. The neutrophil/lymphocyte ratio increased in 95 (57.5%) patients. The mortality rate (24.2%, 11.4%; p=0.03) and requirement of renal replacement therapy (19.1%, 5.7%; p=0.01) were higher in group 1 compared to group 2. In the Cox regression analysis, the basal neutrophil/lymphocyte ratio was the independent predictor of death (HR: 1.23 (95% CI 1.02-1.47), p=0.02), and the basal eGFR was the independent predictor of requirement of renal replacement therapy (HR:0.938, 95% CI: 0.888-0.991, p=0.02). However, platelet/lymphocyte ratio was not associated with death and requirement of renal replacement therapy independently.Conclusion: The neutrophil/lymphocyte ratio predicts all-cause of mortality in geriatric patients with chronic kidney disease. | en_US |
dc.identifier.doi | 10.1080/17843286.2016.1159797 | |
dc.identifier.endpage | 226 | en_US |
dc.identifier.issn | 1784-3286 | |
dc.identifier.issn | 2295-3337 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 27309205 | en_US |
dc.identifier.scopus | 2-s2.0-84976313483 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 221 | en_US |
dc.identifier.uri | https://doi.org/10.1080/17843286.2016.1159797 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/8827 | |
dc.identifier.volume | 71 | en_US |
dc.identifier.wos | WOS:000380152400004 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Acta Clinica Belgica | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chronic kidney disease | en_US |
dc.subject | Geriatric patient | en_US |
dc.subject | Hemodialysis | en_US |
dc.subject | Mortality | en_US |
dc.subject | Neutrophil | en_US |
dc.subject | lymphocyte ratio | en_US |
dc.subject | Platelet | en_US |
dc.subject | lymphocyte ratio | en_US |
dc.title | The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1